Merck to Acquire Cidara Therapeutics for $9.2 Billion in a Strategic Flu Prevention Initiative
The deal gives Merck a potential universal flu solution as the company prepares for a future beyond Keytruda.
We take great pride and responsibility in being able to provide its residents and the greater Montgomery County area with the very best ENT and allergy care possible. This beautiful, new facility enables ENTA to continue doing just that in 2026 and beyond.
The deal gives Merck a potential universal flu solution as the company prepares for a future beyond Keytruda.
With a familiar leader back at the helm and a well-laid plan in place, UnitedHealth is working to steady its operations...
The acquisition brings a novel neurostimulation device into Boston Scientific’s portfolio, expanding its capacity to pro...
AstraZeneca’s Bax24 Phase III trial demonstrates sustained blood pressure control and a favorable safety profile in pati...
The agreement reflects AstraZeneca’s renewed investment push in China through AI-driven development of therapies for chronic illnesses.
“We are incredibly fortunate to have Meg with us, and I look forward to the continued innovation and success her leaders...